Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gut Hormones and Food Intake After RYGB
NCT02336659Completed
- Sponsor
- Copenhagen University Hospital - Hvidovre
- Start
- Apr 2014
- Primary completion
- May 2016
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of exendin 9-39 and sitagliptin in obesity (4 arms), sponsored by Copenhagen University Hospital - Hvidovre. Primary endpoint: Ad libitum food intake. Started Apr 2014; status: completed.
02
Drugs
exendin 9-39sitagliptin
03
Conditions
obesity
Beyond the preview
Go deeper on NCT02336659.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02336659.